RecruitingNot ApplicableNCT06601842

Monitoring and Optimization of Cerebral Perfusion Pressure in Post-cardiac Arrest Patients: a Pilot Study


Sponsor

National Taiwan University Hospital

Enrollment

50 participants

Start Date

Dec 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to establish the ICP and CPP monitoring process and analyze the results in post-arrest patients, to validate the correlation between direct and non-invasive ICP monitoring indicators, to establish a protocol of management of elevated ICP and insufficient CPP in post-arrest care, to establish a protocol for personalizing CPP and MAP optimization, and to analyze its impact on neuroprognosis. Participants will receive ICP monitoring within 12 hours post-ROSC if meet all inclusion and exclusion criteria.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • non-traumatic cardiac arrest
  • admitted to ICU
  • GCS: motor <=5
  • severity: TIMECARD score medium-risk group

Exclusion Criteria9

  • traumatic cardiac arrest
  • pregnancy
  • intracranial hemorrhage
  • coagulopathy
  • anti-platelet or anti-coagulation use
  • terminal illness
  • pre-arrest CPC score >=3
  • GWR < 1.2 on CT or severe hypoxic ischemic encephalopathy
  • CNS infection

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEICP monitoring

ICP monitoring


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06601842


Related Trials